Immunomodulation: a new role for statins? (original) (raw)

Nature Medicine volume 6, pages 1311–1312 (2000)Cite this article

Statins reduce the expression of the class II major histocompatibility complex (MHCII) by arterial cells, leading to a decreased T-cell response. This indicates that statins may be useful in treating graft atherosclerosis and other chronic inflammatory conditions. (pages 1399–1402)

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: Statin modulation of the immune response.

Bob Crimi

References

  1. Maron, D.J., Fazio, S. & Linton, M.F. Current perspectives on statins. Circulation 101, 207–223 (2000).
    Article CAS Google Scholar
  2. Faggiotto, A. & Paoletti, R. State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action. Hypertension 34, 987–996 (1999).
    Article CAS Google Scholar
  3. Kwak, B., Mulhaupt, F., Myit, S. & Mach, F. Statins (HMG-CoA Reductase Inhibitors) as a novel type of immunosuppressor. Nature Med. 6, 1399–1402 (2000).
    Article CAS Google Scholar
  4. Kobashigawa, J.A., et al. Effect of pravastatin on outcomes after cardiac transplantation. N. Engl. J. Med. 333, 621–627 (1995).
    Article CAS Google Scholar
  5. Wenke, K., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation 96, 1398–1402 (1997).
    Article CAS Google Scholar
  6. Mach, B., Steimle, V., Martinez-Soria, E. & Reith, W. Regulation of MHC class II genes: Lessons from a disease. Annu. Rev. Immunol. 14, 301–331 (1996).
    Article CAS Google Scholar
  7. Endres, M., et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 95, 8880–8885 (1998).
    Article CAS Google Scholar
  8. Guijarro, C., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ. Res. 83, 490–500 (1998).
    Article CAS Google Scholar
  9. Liu, L., et al. Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s). J. Biol. Chem. 274, 33334–33340 (1999).
    Article CAS Google Scholar
  10. Genain, C.P. & Zamvil, S.S. Specific immunotherapy: One size does not fit all. Nature Med. 6, 1098–1100 (2000).
    Article CAS Google Scholar
  11. Palinski, W. & Witztum, J.L. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med. 247, 371–380 (2000).
    Article CAS Google Scholar
  12. Napoli, C., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100, 2680–2690 (1997).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, 0682 University of California, San Diego 9500 Gilman Drive, MTF 110, La Jolla, 92093-0682, California
    Wulf Palinski

Authors

  1. Wulf Palinski
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Palinski, W. Immunomodulation: a new role for statins?.Nat Med 6, 1311–1312 (2000). https://doi.org/10.1038/82107

Download citation

This article is cited by